Mankind Pharma Q2 Results: Mankind Pharma on Tuesday reported a 29 per cent rise in its consolidated net profit to Rs 658.88 ...

Pharmaceutical firm Mankind Pharma Ltd on Tuesday (November 5) reported a 30.4% year-on-year (YoY) jump in net profit at ₹653 ...

The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as ...

The company, which also makes Manforce condoms and Prega News pregnancy kits, said its consolidated net profit rose to RS 653 ...

India's Mankind Pharma reported a better-than-expected second-quarter profit on Tuesday, driven by strong demand for its drugs to treat long-term illnesses, such as diabetes and cardiovascular ...

Revenue contribution from Mankind Pharma's mainstay chronic illness drugs segment climbed to 35% from 34%, driving total revenue 14% higher ...

Pharmaceutical M&A came back with a bang during October, after a quiet September. Merck & Co (NYSE: MRK) and AbbVie (NYSE: ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and ...

India's Mankind Pharma reported a stronger-than-expected profit for the second quarter of FY24, driven by higher demand for its medications targeting long-term health conditions like diabetes and ...

Mankind Pharma on Tuesday reported that its consolidated net profit increased 29% in the second quarter of fiscal 2025. The company posted a net profit of Rs 658.88 crore in the quarter ended Sept. 30 ...

Mankind Pharma on Tuesday reported a 29 per cent rise in its consolidated net profit to Rs 658.88 crore for the second quarter ended September 2024, helped by recovery in volume. The company posted a ...

Mankind Pharma's net profit surged 29% to Rs 659 cr in Q2 FY25, driven by volume recovery and strong EBITDA margins. Revenue ...